Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment source : Www.alnylam.com save search
RNAi Roundtable: Lumasiran, for the Treatment of Primary Hyperoxaluria Type 1
Published: 2021-08-19 (Crawled : 14:00) - alnylam.com
ALNY | $148.99 2.2% 130K
|
Health Technology
|
| O: -0.55%
H: 2.32%
C: 0.28%
treatment
RNAi Roundtable: Givosiran, for the Treatment of Acute Hepatic Porphyria
Published: 2021-08-04 (Crawled : 18:00) - alnylam.com
ALNY | $148.99 2.2% 130K
|
Health Technology
|
| O: -0.88%
H: 5.21%
C: 3.5%
treatment hepatitis
RNAi Roundtable: Patisiran & Vutrisiran, in Development for the Treatment of Transthyretin-Mediated Amyloidosis
Published: 2021-07-16 (Crawled : 15:00) - alnylam.com
ALNY | $148.99 2.2% 130K
|
Health Technology
|
| O: 0.62%
H: 2.86%
C: 2.61%
media treatment
RNAi Roundtable: Zilebesiran (ALN-AGT), in Development for the Treatment of Hypertension
Published: 2021-06-30 (Crawled : 15:00) - alnylam.com
ALNY | $148.99 2.2% 130K
|
Health Technology
|
| O: -0.28%
H: 5.14%
C: 2.48%
treatment hypertension
Gainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
CMAX | $4.12 28.35% 65K
|
Manufacturing
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.